Versartis Raises $11 Million
Posted on: June 2, 2009 by PEHub AdministratorNo Comments »
Versartis Inc., a Redwood City, Calif.-based developer of therapeutic proteins for the treatment of metabolic diseases and endocrine disorders, has raised $11 million in Series A funding from Index Ventures. Under terms of the agreement, Index has the option to invest an additional $5 million. Versartis has been formed as a joint venture of Index and Amunix Inc., “to exploit the clinical potential of novel drugs using Amunix’s recombinant PEGylation (rPEG) technology.”
